…and some to hold, avoid or sell

Gym Group Investors Chronicle

The low-cost gym group is opening 20 new sites and trialling a “premium” membership. But increased competition could impinge on growth, and shares are highly rated with little room for error. Sell. 206p.

Halfords Group Investors Chronicle

The car and cycling products retailer has had decent results. But there’s no relief to the downward momentum, nor improvement on margin guidance, and the CEO Jill Mcdonald is leaving to go to Marks & Spencer. Sell. 323p.

Indivior Investors Chronicle

The drug-maker, which majors on treatments for opioid addiction, remains impeded by legal battles and patent disputes. Rising competition for its flagship drug Suboxone could “knock two-thirds off the top line”. Sell. 292.8p.

IQE Investors Chronicle

This high-growth semiconductor supplier has posted a 2% decline in operating profit and a 10% drop in cash generation. There are fears that demand for its “much vaunted VCSEL wafers” was slower than expected. Sell. 146p.

Sophos Group The Times

Shares in the cybersecurity specialist have reached their highest point since floating in 2015 as customer billings increase, giving strong forward visibility. But the high valuation is worrying: take profits. Sell. 521.5p.

Victrex The Times

A tax cut, due to a Government scheme to encourage innovation, sent shares in the plastics specialist soaring. But Hurricane Harvey will hit demand from US oil refineries, and it faces a new rival in Georgia. Take profits. £22.20.